By Dr Simon Ghaly

Journal articles

Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2025, 'Oral microbial diversity is associated with biologic treatment and metabolic health status but not with disease activity in patients with inflammatory bowel disease', Crohn's & Colitis 360, pp. otaf047, http://dx.doi.org/10.1093/crocol/otaf047

Suo P; Srinivasan A; Thin L; An YK; Fernandes R; Ghaly S; Jeffrey A; Menon S; Olsen N; Skinner T; van Langenberg D; Winston J; Haifer C, 2025, 'Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern', Journal of Gastroenterology and Hepatology Australia, 40, pp. 1174 - 1181, http://dx.doi.org/10.1111/jgh.16916

O’Neill RS; Field A; Kim BSM; Ferguson JS; Ghaly S; Dear RF, 2025, 'Duodenal obstruction secondary to metastatic breast cancer', Journal of Cancer Research and Therapeutics, 21, pp. 755 - 757, http://dx.doi.org/10.4103/jcrt.jcrt_2022_24

Su WK; McNamara J; Wilson W; Wark G; Lynch K; Su H; Forbes A; Lawrance I; An YK; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'DOP015 Consistency and Quality of Inflammatory Bowel Disease care in Australasia; Towards Benchmarking, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i111 - i112, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0054

Davidson C; Su WK; Wilson W; Rivas C; Antoniades S; Wark G; Su H; Ghaly S; Grafton R; Andrews JM; Connor SJ, 2025, 'N26 Factors associated with Inflammatory Bowel Disease (IBD) helpline (HL) utilisation: Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i2481 - i2482, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1558

Koentgen S; Cosier D; Tavakoli P; Leach ST; Dutt S; Ghaly S; Connor SJ; Lemberg DA; Lambert K; Hold GL, 2025, 'P0018 Fat rich dietary habits: Further increasing IBD risk in first degree relatives', Journal of Crohn's and Colitis, 19, pp. i358 - i358, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0192

Tearle J; Zhang F; Jackson K; Malhotra P; Tavakoli P; Koentgen S; Warren J; Williams C; Haque A; Arzivian A; Tedla N; Kim A; King H; Hold G; Ghaly S; James K, 2025, 'P0161 The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing', Journal of Crohn's and Colitis, 19, pp. i557 - i557, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0335

Koentgen S; Zhang F; Wu N; Jayawardana T; Little R; Tavakoli P; Ghaly S; Connor SJ; Hold GL, 2025, 'P0203 Unique faecal & oral microbiota signatures in first degree relatives of inflammatory bowel disease patients', Journal of Crohn's and Colitis, 19, pp. i607 - i607, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0377

Pudipeddi A; Dhanji P; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i689 - i690, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0431

Su WK; Wilson W; Wark G; Ghaly S; Lynch K; Lawrance I; Walker G; Forbes A; Brett L; An YK; Connor SJ; Andrews JM, 2025, 'P0603 The real-world use of intravenous and subcutaneous Vedolizumab in IBD across Australia and New Zealand, Crohn’s Colitis Cure Data Insight’s Program', Journal of Crohn's and Colitis, 19, pp. i1197 - i1198, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0777

Khaing MM; Fernandes RG; An YK; Baraty B; Bryant RV; Ghaly S; Smith RL; Srinivasan A; Hay K; Begun J, 2025, 'P0660 Comparative Accuracy and Reliability of Handheld versus Cart-Based Ultrasound in assessing Inflammatory Bowel Disease Activity', Journal of Crohn's and Colitis, 19, pp. i1290 - i1292, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0834

Pudipeddi A; Lin H; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong R, 2025, 'P0754 Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial', Journal of Crohn's and Colitis, 19, pp. i1453 - i1454, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0928

Cosier D; Lambert K; Karen C; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg D; Houshyar Y; Jayawardana T; Koentgen S; Hold G, 2025, 'P0759 The interplay between dietary intake and disease activity in Australian adults with and without Inflammatory Bowel Disease', Journal of Crohn's and Colitis, 19, pp. i1465 - i1465, http://dx.doi.org/10.1093/ecco-jcc/jjae190.0933

Rivas C; Su WK; Wilson W; Ng W; Ghaly S; Walker G; Forbes A; Su H; Schultz M; Lawrance I; Dutt S; Brett L; Begun J; Lynch K; Andrews JM; Connor S, 2025, 'P1132 Patterns and predictors of steroid use in people with IBD in routine care across ANZ', Journal of Crohn's and Colitis, 19, pp. i2073 - i2073, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1306

Gu B; Su WK; Nano D; Wilson W; Iliescu S; Lynch K; Andrews JM; Connor SJ; Ghaly S, 2025, 'P1281 Active perianal fistulising Crohn’s Disease is associated with a higher burden of psychological distress, depression, anxiety, stress and opioid use', Journal of Crohn's and Colitis, 19, pp. i2311 - i2312, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1455

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Tavakoli P; Sidhu S; Le A; Boussioutas A; Ward MG; Miles P S; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G, 2025, 'P1327 Microbial signatures associated with Inflammatory Bowel Disease in Australia: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2388 - i2389, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1501

Little R; Jayawardana T; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'P1340 Gut microbiota changes are associated with type of advanced therapy in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2410 - i2412, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1514

Jayawardana T; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward MG; Sparrow MP; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold G, 2025, 'P1344 Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2419 - i2421, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1518

Little R; Jayawardana T; Zhang F; Houshyar Y; Koentgen S; Wu N; Ellepola A; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson P; Ghaly S; Corte C; Talley N; Leach S; Lemberg D; Dutt S; Paramsothy S; Leong R; Connor S; Hold G, 2025, 'P1345 Association of gut microbiota changes and disease activity in patients with Crohn’s disease and ulcerative colitis: baseline data from the Australian IBD Microbiome study', Journal of Crohn's and Colitis, 19, pp. i2422 - i2423, http://dx.doi.org/10.1093/ecco-jcc/jjae190.1519

McNamara J; Wilson W; Pipicella JL; Ghaly S; Begun J; Lawrance IC; Gearry R; Andrews JM; Connor SJ, 2025, 'Epidemiology and Treatment Patterns of Fistulizing Crohn's Disease in a Large, Real-World Australasian Cohort', Gastro Hep Advances, 4, http://dx.doi.org/10.1016/j.gastha.2024.100594

Skinner TA; O'neill RS; Ghaly S; Low JP; Van Laar Veth A; Feller RB, 2025, 'Ileal ulceration and haematochezia in an 83-year old', Frontline Gastroenterology, http://dx.doi.org/10.1136/flgastro-2025-103067

Su WK; McNamara J; Wilson WE; Wark G; Lynch KD; Su HY; Forbes AJ; Lawrance IC; An Y-K; Dutt S; Brett L; Walker G; Andrews JM; Connor SJ; Ghaly S, 2025, 'Mo1954: CONSISTENCY AND QUALITY OF INFLAMMATORY BOWEL DISEASE CARE IN AUSTRALASIA; TOWARDS BENCHMARKING.', Gastroenterology, 169, pp. S - 1240, http://dx.doi.org/10.1016/s0016-5085(25)03741-2

Jayawardana TC; Little RD; Zhang F; Koentgen S; Wu N; Houshyar Y; Tavakoli P; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong RW; Connor SJ; Hold GL, 2025, 'Mo1960: IMPAIRED HEALTH-RELATED QUALITY OF LIFE IS ASSOCIATED WITH ALTERATIONS IN GUT MICROBIOTA SIGNATURES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY.', Gastroenterology, 169, pp. S - 1243, http://dx.doi.org/10.1016/s0016-5085(25)03747-3

Sin HCL; Baraty B; Li V; Ghaly S; Haifer C, 2025, 'Mo2118: INTESTINAL ULTRASOUND IN IMMUNE CHECKPOINT INHIBITORRELATED COLITIS', Gastroenterology, 169, pp. S - 1290, http://dx.doi.org/10.1016/s0016-5085(25)03850-8

Little RD; Jayawardana TC; Zhang F; Koentgen S; Wu N; Tavakoli P; Chung A; Ho A; Read S; Boussioutas A; Ward M; Sparrow M; Gibson PR; Ghaly S; Corte C; Talley NJ; Leach ST; Lemberg DA; Dutt S; Paramsothy S; Leong R; Connor SJ; Hold GL, 2025, 'Sa1795: GUT MICROBIOTA CHANGES ARE ASSOCIATED WITH TYPE OF ADVANCED THERAPY IN PATIENTS WITH IBD: BASELINE DATA FROM THE AUSTRALIAN IBD MICROBIOME STUDY', Gastroenterology, 169, pp. S - 532, http://dx.doi.org/10.1016/s0016-5085(25)02163-8

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1899: EXTENSIVE DISEASE CLEARANCE AS A NOVEL COMPOSITE ENDPOINT TO PREDICT LONG-TERM RELAPSE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. S - 879, http://dx.doi.org/10.1016/s0016-5085(25)02960-9

Pudipeddi A; Paramsothy S; Kariyawasam VC; Paramsothy R; Ghaly S; Haifer C; An Y-K; Begun J; Connor SJ; Corte C; Ward M; De Cruz P; Fung CL; Redmond D; Chan PW; Mourad FH; Kermeen M; Leong R, 2025, 'Su1943: CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL', Gastroenterology, 169, pp. S - 900, http://dx.doi.org/10.1016/s0016-5085(25)03004-5

Rivas C; Su WK; Wilson WE; Ng W; Ghaly S; Walker G; Forbes AJ; Su H; Schultz M; Lawrance IC; Dutt S; Brett L; Begun J; Lynch KD; Andrews JM; Connor SJ, 2025, 'Tu1094: PATTERNS AND PREDICTORS OF STEROID USE IN PEOPLE WITH IBD IN ROUTINE CARE ACROSS ANZ', Gastroenterology, 169, http://dx.doi.org/10.1016/s0016-5085(25)03886-7

Cosier D; Lambert K; Charlton K; Batterham M; Little RD; Wu N; Tavakoli P; Ghaly S; Pipicella JL; Connor S; Leach S; Lemberg DA; Houshyar Y; Jayawardana T; Koentgen S; Hold GL, 2024, 'Dietary Patterns and Fibre Intake Are Associated with Disease Activity in Australian Adults with Inflammatory Bowel Disease: An Exploratory Dietary Pattern Analysis †', Nutrients, 16, http://dx.doi.org/10.3390/nu16244349

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor SJ; Corte C; Ward MG; De Cruz P; Lan-San Fung C; Redmond D; Chan W; Mourad F; Kermeen M; Leong RW, 2024, 'Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial', Clinical Gastroenterology and Hepatology, 22, pp. 2299 - 2308.e5, http://dx.doi.org/10.1016/j.cgh.2024.04.019

Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2024, 'Dietary Determinants of Metabolic and Gut Microbial Health in Patients with Inflammatory Bowel Disease', Nutrients, 16, http://dx.doi.org/10.3390/nu16193233

Katsoudas N; Tavakoli P; Wu N; Shapiro A; Leach ST; Williams AJ; Paramsothy R; Ghaly S; Connor SJ; Samocha-Bonet D; Lambert K; Hold GL, 2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250, http://dx.doi.org/10.1093/ibd/izad318

Alshiwanna B; Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1005 Dose escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1809 - i1809, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1135

Barnett M; Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P1012 Dose escalated Ustekinumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1820 - i1820, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1142

Pipicella JL; Wilson W; Ghaly S; Antoniades S; Kate L; Grafton R; Ng W; Sechi A; Somes K; Arnold K; Connor SJ; Andrews JM, 2024, 'P1030 Inflammatory Bowel Disease helpline contact trends in a real-world Australasian cohort: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1849 - i1850, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1160

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P1129 Fistulising Crohn's Disease in a large Australasian cohort - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i2010 - i2010, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1259

Wark G; Kaakoush NO; Samocha-Bonet D; Ghaly S; Danta M, 2024, 'P1233 Serum insulin is associated with c-reactive protein and gut microbial diversity in inflammatory bowel disease', Journal of Crohn's and Colitis, 18, pp. i2171 - i2171, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1363

Mcnamara J; Wilson W; Pipicella J; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JM; Connor SJ, 2024, 'P286 Variation of outcomes in inflammatory bowel disease at ten Australasian centres - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i650 - i650, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0416

Mcnamara J; Wilson W; Pipicella JL; Ghaly S; Gearry R; Williams A; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Connor SJ; Andrews JM, 2024, 'P462 The burden of mental health disease in people with inflammatory bowel disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i923 - i923, http://dx.doi.org/10.1093/ecco-jcc/jjad212.0592

Pipicella JL; McNamara J; Wilson W; Lynch K; Walker G; Begun J; Lawrance I; Ghaly S; Radford-Smith G; Williams AJ; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'P880 The real-world use of five-aminosalicylate (5ASA) treatment for Ulcerative Colitis in Australia and New Zealand: Crohn’s Colitis Cure (CCC) data insight’s program', Journal of Crohn's and Colitis, 18, pp. i1612 - i1613, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1010

Mcnamara J; Alshiwanna B; Wilson W; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch K; Lawrance I; Schultz M; Walker G; Radford-Smith G; Andrews JA; Connor SJ, 2024, 'P959 Dose escalated vedolizumab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program', Journal of Crohn's and Colitis, 18, pp. i1732 - i1732, http://dx.doi.org/10.1093/ecco-jcc/jjad212.1089

Lim E; Thai M; An Y-K; Hendy P; Alchlaihawi M; Leong R; Connor S; Ng W; Gu B; Thin L; Sparrow M; Gilmore R; Taylor K; Sallis O; Andrews JM; Daker C; Gearry RB; Wark G; Ghaly S; Begun M; Krishnaprasad K; Wu T; Ruddick-Collins L; Schreiber V; Okano S; Radford-Smith G; Schulberg J; van Langenberg D; Begun J, 2024, 'High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease', GastroHep, 2024, http://dx.doi.org/10.1155/2024/3686618

Barnett MI; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1833 DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03072-5

McNamara J; Alshiwanna B; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135, http://dx.doi.org/10.1016/s0016-5085(24)03073-7

Alshiwanna B; McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Mo1835 DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 1135, http://dx.doi.org/10.1016/s0016-5085(24)03074-9

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Begun J; Ng W; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Andrews JM; Connor SJ, 2024, 'Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, pp. S - 839, http://dx.doi.org/10.1016/s0016-5085(24)02405-3

McNamara J; Wilson WE; Pipicella JL; Ghaly S; Gearry R; Williams A-J; Lynch KD; Lawrance IC; Schultz M; Walker GJ; Radford-Smith GL; Connor SJ; Andrews JM, 2024, 'Su1874 THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)02438-7

Pipicella JL; McNamara J; Wilson WE; Lynch KD; Walker GJ; Begun J; Lawrance IC; Ghaly S; Radford-Smith GL; Williams A-J; Gearry R; Schultz M; Brett L; Andrews JM; Connor SJ, 2024, 'Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)03792-2

Pudipeddi A; Paramsothy S; Kariyawasam V; Paramsothy R; Ghaly S; Haifer C; An YK; Begun J; Connor S; Corte C; Ward M; De Cruz P; Fung C; Redmond D; Leong RW, 2023, 'P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial', Journal of Crohn's and Colitis, 17, pp. i542 - i543, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0543

Cheema M; Narouz I; Pipicella J; Garden F; Lynch K; Andrews J; Ghaly S; Connor S, 2023, 'P523 Quality, safety and equity of care outcomes for inflammatory bowel disease patients at four tertiary referral centres in Australia using a cloud based management system Crohn’s Colitis Care (CCCare): A real world observational study.', Journal of Crohn's and Colitis, 17, pp. i650 - i651, http://dx.doi.org/10.1093/ecco-jcc/jjac190.0653

Back to profile page